CTPharma

CTPharma, officially known as Connecticut Pharmaceutical Solutions, is a leading medical cannabis producer and research company based in Rocky Hill, Connecticut. The company operates a state-of-the-art 216,000-square-foot cultivation and manufacturing facility where it produces a wide range of pharmaceutical-grade cannabis products, including flower, oils, and specialized dosage forms like tablets. CTPharma is distinguished in the industry by its commitment to scientific validation, notably through its research partnership with the Yale School of Medicine to study the efficacy of cannabinoids in treating various medical conditions. In December 2021, the company was acquired by Verano Holdings, a prominent multi-state cannabis operator, for approximately $101 million. Despite the acquisition, CTPharma continues to operate as a key brand within the Connecticut medical and adult-use markets, maintaining its focus on high-quality, science-based product development.